In vivo inhibition of prostaglandin e2 production by crude aqueous extract of the root bark of zanthoxylumxanthoxyloides
Background: Crude aqueous extract of the root bark of Zanthoxylum xanthoxyloides is used in folklore medicine for its anti-inflammatory activity. Although it shares the analgesic and anti-inflammatory property
of non-steroidal anti-inflammatory drugs (NSAIDs), its mechanism of action has not been well elucidated. Objective: To ascertain whether the extract decreases carrageenin-induced increase in plasma prostaglandin
E2 (PGE2) concentration with the view to shed light on the mechanism of action.
Methods: The extract was obtained by Soxhlet extraction and rotatory evaporation, followed by freezedrying. Forty Wistar rats (150g - 200g) were assigned to 8 groups of 5 rats each. The rats were given four
different treatments orally: 0.9% saline (two groups of control); two groups received indomethacin, 20mg/kg and 40mg/kg respectively; another two groups received the extract, 2000mg/kg and 4000mg/kg respectively;
and the remaining two groups, 50mg/kg and 100mg/kg nimesulide respectively. Inflammation was induced with carrageenin in one of the two groups of control. Enzyme-linked immunospecific assay was used to
measure plasma PGE2 concentration in the control and treated groups of rats. Analysis of variance was used as the statistical test. Differences in means at p<0.05 were considered significant.
Results: Carrageenin increased plasma PGE2 concentration which was reduced by the extract, indomethacin and nimesulide. High dose extract and indomethacin reduced plasma PGE2 concentration to a comparable
extent which was much greater than that of the reduction caused by nimesulide.
Conclusion: It was concluded that the extract might act by non-selective inhibition of cyclooxygenase 1 and 2 to decrease plasma PGE2 concentration.
Articles published in the Ghana Medical Journal may not be published elsewhere without the consent of the publishers. Request for consent for reproduction of material published in the Ghana Medical Journal should be addressed to the Editor-in-Chief. The publisher of this Journal reserves the right of copyright of all articles published in the Journal. It should also be understood by all authors that articles approved for publication in the journal are also deemed for publication online by the publisher.
Ghana Medical Journal is an Open Access journal and applies the Creative Commons Attribution (CC BY) license (Creative Commons Attribution License) 4.0 International. See details on the Creative Commons website (https://creativecommons.org/licenses/by/4.0/) to articles and other content published in the Journal.